Is Xolair Safe During Pregnancy?
Xolair (omalizumab) is not recommended during pregnancy due to limited data and potential fetal risks. Animal studies show no direct harm, but human evidence is sparse, with most exposure data from post-marketing reports involving about 250 pregnancies. No clear pattern of malformation or miscarriage emerges from these cases, but outcomes remain uncertain without large controlled trials.[1][2]
The prescribing information classifies it as Pregnancy Category B (old FDA system), meaning animal reproduction studies show no fetal risk, but adequate human studies are lacking. Clinicians often weigh benefits against risks for severe asthma or chronic hives, as uncontrolled conditions can harm both mother and fetus.[1]
What Do Pregnancy Registries Show?
The Xolair Pregnancy Registry (via MotherToBaby) tracks outcomes in exposed women. Early data through 2018 reported live births in most cases, with miscarriage rates similar to the general population (around 15-20%), and no increased birth defects. However, small sample sizes limit conclusions, and long-term effects on infants are unknown.[2][3]
Ongoing registries like EXPECT (for asthma) continue monitoring, but no definitive safety signal exists yet.
Alternatives for Asthma or Hives in Pregnancy?
Safer first-line options include:
- Inhaled corticosteroids (e.g., budesonide, preferred for asthma).
- Long-acting beta-agonists like formoterol.
- For hives, nonsedating antihistamines (loratadine, cetirizine) after the first trimester.
These have stronger safety profiles from extensive use.[4]
What Risks Are Documented?
Potential concerns include:
- Immunoglobulin G (IgG) crossing the placenta, possibly affecting fetal immune development.
- Theoretical anaphylaxis risk from the drug itself.
- Exacerbation of maternal conditions if discontinued abruptly.
Breastfeeding data is also limited; it's unknown if Xolair passes into milk in clinically significant amounts.[1][2]
When Might a Doctor Prescribe It Anyway?
In life-threatening cases where benefits outweigh risks, such as severe, uncontrolled allergic asthma. Discuss with an allergist or obstetrician; they may monitor via ultrasound or refer to registries. Always report exposure promptly.[3]
Sources:
[1] Xolair Prescribing Information (Genentech/Novartis)
[2] Drugs.com - Xolair Pregnancy Data
[3] MotherToBaby Fact Sheet on Omalizumab
[4] ACOG Guidelines on Asthma in Pregnancy